Raj is the Chief Medical Officer. Prior to enGene, he was the Global Medical Affairs Leader, Bladder Cancer and Senior Medical Director, Oncology (Global – Prostate and Bladder Cancer) at Johnson and Johnson Innovative Medicine.

He actively maintains multiple prominent leadership roles within the urological community. He is the Chair of the Advisory Council for Urology of the American College of Surgeons and serves on its Board of Governors. He is currently an Adjunct Professor in the Department of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell and previously served as Professor and Chair of both the UCSF Department of Urology and the Department of Urology at the University of North Carolina, Chapel Hill.

Raj was previously a member of the American Board of Urology (ABU)/ American Urological Association (AUA) Examination Committee and is Past-President for the Society of Academic Urology. He served on the Guidelines Committee and helped to develop the AUA Guidelines on the Management of Non-muscle Invasive Bladder Cancer, and also served on the Bladder Cancer Guidelines Committee of the International Consultation on Urological Diseases.

Raj graduated from Duke University School of Medicine and completed his residency and post-graduate training in Urologic Surgery at Stanford University. He also holds a Master of Health Administration from the University of North Carolina at Chapel Hill.

• 

  Chief Medical Officer in enGene

  Mainstreaming Gene Therapy